Stock listing
NYSE American:SRXH SRx Health Solutions, Inc. Stock
Home listing (NYSE American) of SRx Health Solutions, Inc.
Follow SRx Health Solutions, Inc. into a list and get an email when it puts out news.
Share price · AMEX:SRXH
$0.80 USD -0.23 (-22.3%)
Close on Nov 20, 2026
- Day range
- $0.79 – $0.996 USDNov 20, 2026
- Volume
- 1.08M sharesNov 20, 2026
- Market cap
- $16.21M USDAt the close on Nov 20, 2026 · price × 20.27M shares outstanding
- 52-week range
- $0.71 – $42.60 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $850,903 USDMedian day 511,950 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE American:SRXH · Home | $0.80 USD | -0.23 (-22.3%) | 1,078,600 | $0.99 | $0.996 | $0.79 | $1.03 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · AMEX:SRXH · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.80 | -0.23 | -22.3% | $0.99 | $0.996 | $0.79 | 1,078,600 | |
| $1.03 | +0.03 | +3.0% | $0.995 | $1.21 | $0.97 | 1,138,400 | |
| $1.00 | +0.113 | +12.7% | $0.901 | $1.03 | $0.893 | 355,200 | |
| $0.887 | -0.045 | -4.8% | $0.946 | $0.96 | $0.875 | 322,300 | |
| $0.932 | -0.02 | -2.1% | $0.93 | $1.06 | $0.881 | 390,400 | |
| $0.952 | +0.011 | +1.2% | $0.947 | $0.975 | $0.913 | 145,800 | |
| $0.941 | +0.061 | +6.9% | $0.90 | $1.02 | $0.90 | 532,900 | |
| $0.88 | -0.063 | -6.7% | $0.918 | $0.945 | $0.88 | 217,600 | |
| $0.943 | +0.073 | +8.4% | $0.889 | $0.97 | $0.851 | 398,200 | |
| $0.87 | +0.058 | +7.1% | $0.82 | $0.91 | $0.71 | 786,700 | |
| $0.812 | +0.012 | +1.5% | $0.808 | $0.838 | $0.79 | 285,800 | |
| $0.80 | -0.087 | -9.8% | $0.88 | $0.88 | $0.775 | 553,100 | |
| $0.887 | -0.078 | -8.1% | $0.92 | $0.979 | $0.88 | 339,900 | |
| $0.965 | -0.005 | -0.5% | $0.977 | $0.992 | $0.87 | 350,100 | |
| $0.97 | -0.04 | -4.0% | $0.99 | $1.08 | $0.942 | 510,200 | |
| $1.01 | 0.00 | 0.0% | $0.97 | $1.05 | $0.85 | 1,134,100 | |
| $1.01 | -0.03 | -2.9% | $1.04 | $1.07 | $1.00 | 281,500 | |
| $1.04 | -0.04 | -3.7% | $1.09 | $1.093 | $1.03 | 169,100 | |
| $1.08 | +0.04 | +3.8% | $1.04 | $1.10 | $1.03 | 278,000 | |
| $1.04 | -0.03 | -2.8% | $1.00 | $1.10 | $0.995 | 692,000 | |
| $1.07 | -0.02 | -1.8% | $1.08 | $1.10 | $1.047 | 390,500 | |
| $1.09 | -0.01 | -0.9% | $1.07 | $1.12 | $1.04 | 472,700 | |
| $1.10 | -0.04 | -3.5% | $1.14 | $1.15 | $1.10 | 362,200 | |
| $1.14 | -0.01 | -0.9% | $1.15 | $1.16 | $1.10 | 245,400 | |
| $1.15 | -0.04 | -3.4% | $1.19 | $1.30 | $1.14 | 375,400 | |
| $1.19 | -0.06 | -4.8% | $1.22 | $1.248 | $1.17 | 348,300 | |
| $1.25 | -0.04 | -3.1% | $1.27 | $1.28 | $1.20 | 603,600 | |
| $1.29 | -0.08 | -5.8% | $1.36 | $1.39 | $1.26 | 534,900 | |
| $1.37 | +0.01 | +0.7% | $1.36 | $1.45 | $1.36 | 244,900 | |
| $1.36 | -0.10 | -6.8% | $1.45 | $1.45 | $1.35 | 330,500 | |
| $1.46 | +0.06 | +4.3% | $1.42 | $1.50 | $1.42 | 468,000 | |
| $1.40 | -0.09 | -6.0% | $1.50 | $1.50 | $1.39 | 1,324,900 | |
| $1.49 | +0.01 | +0.7% | $1.54 | $1.63 | $1.47 | 1,875,400 | |
| $1.48 | -0.01 | -0.7% | $1.50 | $1.53 | $1.48 | 908,200 | |
| $1.49 | -0.12 | -7.5% | $1.58 | $1.585 | $1.47 | 608,200 | |
| $1.61 | 0.00 | 0.0% | $1.62 | $1.64 | $1.58 | 474,200 | |
| $1.61 | +0.06 | +3.9% | $1.56 | $1.635 | $1.50 | 619,800 | |
| $1.55 | -0.05 | -3.1% | $1.58 | $1.60 | $1.55 | 247,100 | |
| $1.60 | +0.02 | +1.3% | $1.69 | $1.69 | $1.58 | 399,100 | |
| $1.58 | -0.12 | -7.1% | $1.68 | $1.68 | $1.575 | 513,700 | |
| $1.70 | -0.03 | -1.7% | $1.73 | $1.79 | $1.675 | 1,054,300 | |
| $1.73 | +0.03 | +1.8% | $1.70 | $1.79 | $1.692 | 758,600 | |
| $1.70 | -0.08 | -4.5% | $1.77 | $1.82 | $1.68 | 880,300 | |
| $1.78 | +0.06 | +3.5% | $1.74 | $1.83 | $1.68 | 921,300 | |
| $1.72 | +0.05 | +3.0% | $1.72 | $1.85 | $1.66 | 1,160,900 | |
| $1.67 | +0.05 | +3.1% | $1.64 | $1.79 | $1.64 | 1,153,300 | |
| $1.62 | +0.02 | +1.3% | $1.63 | $1.658 | $1.57 | 358,600 | |
| $1.60 | -0.11 | -6.4% | $1.70 | $1.72 | $1.57 | 461,800 | |
| $1.71 | +0.03 | +1.8% | $1.65 | $1.72 | $1.627 | 438,300 | |
| $1.68 | +0.09 | +5.7% | $1.58 | $1.699 | $1.56 | 880,700 | |
| $1.59 | +0.03 | +1.9% | $1.58 | $1.665 | $1.55 | 570,200 | |
| $1.56 | +0.05 | +3.3% | $1.48 | $1.64 | $1.47 | 984,600 | |
| $1.51 | -0.07 | -4.4% | $1.56 | $1.60 | $1.51 | 444,600 | |
| $1.58 | +0.07 | +4.6% | $1.51 | $1.60 | $1.51 | 358,100 | |
| $1.51 | -0.05 | -3.2% | $1.56 | $1.565 | $1.49 | 346,800 | |
| $1.56 | 0.00 | 0.0% | $1.55 | $1.59 | $1.50 | 719,400 | |
| $1.56 | -0.07 | -4.3% | $1.61 | $1.646 | $1.52 | 538,200 | |
| $1.63 | -0.05 | -3.0% | $1.66 | $1.70 | $1.59 | 673,700 | |
| $1.68 | -0.03 | -1.8% | $1.70 | $1.71 | $1.62 | 805,200 | |
| $1.71 | -0.04 | -2.3% | $1.77 | $1.78 | $1.706 | 597,200 | |
| $1.75 | -0.09 | -4.9% | $1.84 | $2.015 | $1.75 | 1,392,900 | |
| $1.84 | +0.04 | +2.2% | $1.77 | $1.87 | $1.73 | 758,000 | |
| $1.80 | -0.01 | -0.6% | $1.82 | $1.84 | $1.76 | 584,400 | |
| $1.81 | -0.05 | -2.7% | $1.86 | $1.86 | $1.773 | 387,600 | |
| $1.86 | +0.05 | +2.8% | $1.85 | $1.94 | $1.821 | 688,600 | |
| $1.81 | -0.06 | -3.2% | $1.86 | $1.88 | $1.799 | 393,500 |
Splits
5 splits since 2012 · AMEX:SRXH · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-60 | Consolidation | |
| 1-for-40 | Consolidation | |
| 1-for-6 | Consolidation | |
| 1-for-26 | Consolidation | |
| 1-for-1000 | Consolidation |
- Ticker
- NYSE American:SRXH
- Asset type
- Stock
- Sector
- Financials
- Industry
- Investment companies & funds
- Exchange
- NYSE American
- Currency
- USD
What changed lately
Latest news release · Aug 4, 2026
SRX Global (SRXH) Acquires Stake in Vistagen Therapeutics
Latest deck · July 2026
SRX Global — Investor Presentation (July 2026)
Investor deck · 18 slides
Latest news
SRX Global (SRXH) Acquires Stake in Vistagen Therapeutics
Aug 4, 2026
Closed $1.37 (-4.9%) on Aug 4, 2026
SRX Global Board of Directors Authorizes Stock Repurchase Plan of Up to 10 Million Shares or Up to 50% of its Shares Outstanding
Jul 9, 2026
Closed $2.53 (+28.4%) on Jul 9, 2026
SRX Global Reports Preliminary Net Asset Value of Approximately $3.07 Per Share and Over $55 Million in Cash and Short-Term Investments(1)
Jul 8, 2026
Closed $1.97 (+45.9%) on Jul 8, 2026
SRx Health Solutions Closes EMJX Acquisition and Launches AI-Driven Platform Strategy Under New Name and Brand, SRX Global, Focused on Investments in High-Conviction Operating Companies and Assets
Jun 18, 2026
Closed $7.50 (-37.5%) on Jun 18, 2026
SRx Health Solutions Acquires 4.99% of Smartkem, Inc. (NASDAQ: SMTK)
Jun 8, 2026
Closed $7.50 (+3.3%) on Jun 8, 2026
SRx Health Solutions Invests in Uber Technologies, Inc. and Provides Shareholders with Portfolio Update
May 29, 2026
Closed $6.66 (-4.3%) on May 29, 2026
SRx Health Solutions Announces Board Approval to Dividend 75% of Profits from Investment in Astro Investment XVII
May 18, 2026
Closed $7.50 (0.0%) on May 18, 2026
SRx Health Solutions Announces Board Approval to Dividend 75% of Profits from Investment in Astro Investment XVII, an Affiliate of Astro Capital and SPV with Investments in SpaceX and Other Artificial Intelligence and Space Companies
May 15, 2026
Closed $7.50 (-9.4%) on May 15, 2026
SRx Health Solutions Announces Fiscal Second Quarter 2026 Results for Quarter Ended March 31, 2026
May 14, 2026
Closed $7.50 (-9.4%) on May 15, 2026
SRx Health Solutions Invests in Astro Investment XVII, an Affiliate of Astro Capital
Apr 22, 2026
Closed $7.20 (+1.7%) on Apr 22, 2026
SRx Health Solutions, Inc. on 6ix
- Sector
- Financials
- Industry
- Investment companies & funds
- News releases
- 26 in the last 12 months · 39 in all · newest Aug 4, 2026 · oldest 2025
- Decks
- 21 decks · latest July 2026
Where SRx Health Solutions, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE American:SRXH · Home listing · This page | NYSE American | United States | USD |
| BOATS:SRXH | BOATS | United States | USD |
Valuation
Price/book 0.1× against a median of 0.7×: the lowest of 11 Investment companies & funds companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- −$26.48M USD
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 0.1×
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 1.33
Investment companies & funds: the 10 companies nearest in size, of 321 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| SRx Health Solutions, Inc. · AMEX:SRXH | US$16.21M | −US$26.48M | n/a | n/a | n/a | 0.1× | n/a | 0.0× | 1.33 |
| Wilmington Capital Management Inc. Class A · TSX:WCM.A | US$18.52M | US$16.73M | 3.3× | 10.7× | 3.1× | 0.6× | 359.9% | 0.0× | 0.30 |
| ORECAP Invest Corp · TSXV:OCI | US$18.18M | −US$11.59M | 1.4× | n/a | n/a | 0.6× | n/a | 0.0× | 1.08 |
| Panostaja Oyj · OMXHEX:PNA1V | US$18.04M | US$59.64M | n/a | 0.5× | 1.3× | 0.8× | −3.9% | 2.6× | n/a |
| Innovative-RFK SpA · EURONEXT:MLIRF | US$17.97M | US$18.17M | 11.8× | 42.7× | n/a | 1.3× | 359.0% | 0.1× | n/a |
| Numeral Limited · JSE:XII | US$17.74M | US$22.31M | n/a | 10.5× | 21.3× | 23.6× | −1.9% | 6.3× | n/a |
| Mineral and Financial Investments Ltd · LSE:MAFL | US$17.03M | US$631,481 | 6.0× | 0.3× | n/a | 0.8× | 156.9% | 0.0× | n/a |
| EMV Capital PLC · LSE:EMVC | US$16.60M | US$16.81M | n/a | 4.5× | n/a | 0.4× | −0.7% | 0.0× | n/a |
| China Innovation Investment Limited · HKEX:1217 | US$16.33M | −US$15.36M | 2.3× | −1.9× | −2.1× | 0.2× | 87.8% | 0.0× | n/a |
| Frontier IP Group PLC · LSE:FIPP | US$16.21M | US$30.65M | n/a | 72.1× | n/a | 0.3× | n/a | 0.3× | n/a |
| Trematon Capital Investments Limited · JSE:TMT | US$15.52M | US$23.68M | n/a | 1.4× | 36.8× | 1.0× | −23.3% | 0.8× | n/a |
| Median of the others | US$17.39M | US$17.49M | 3.3× | 4.5× | 3.1× | 0.7× | 43.5% | 0.1× | 0.69 |
Team and board
Officers
| Officer | Role |
|---|---|
| Kent Cunningham | Chief Executive Officer |
| Nina Martinez | Chief Financial Officer |
| Eric Jackson | President, EMJX Platform and Head of Asset Management |
Board
| Director | Role |
|---|---|
| Michael Young | Chairman of the Board |
| Joshua A. Epstein | Director |
| Sammy Dorf | Director |
| Simon Conway | Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Aug 13, 2026 · After close | +4.9% |
| Q3 2025 | Sep 30, 2025 | −5.3% |
| Q2 2025 | May 15, 2025 | −40.7% |
| Q4 2025 | Mar 31, 2025 | 0.0% |
| Q4 2024 | Nov 13, 2024 | −14.1% |
| Q3 2024 | Aug 14, 2024 | −5.5% |
| Q2 2024 | Apr 15, 2024 | +4.7% |
| Q4 2023 | Nov 13, 2023 | −11.2% |
| Q3 2023 | Aug 21, 2023 | +6.5% |
| Q2 2023 | May 12, 2023 | +0.7% |
All 19 quarters
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Dec 31, 2022 | Mar 28, 2023 | −16.7% |
| Q4 2022 | Nov 10, 2022 | −1.2% |
| Q3 2022 | Aug 11, 2022 | −21.2% |
| Q2 2022 | May 12, 2022 | +21.4% |
| Quarter to Dec 31, 2021 | Mar 29, 2022 | −0.4% |
| Q4 2021 | Nov 10, 2021 | −0.8% |
| Q3 2021 | Aug 12, 2021 | −8.8% |
| Q2 2021 | Jun 2, 2021 | −2.5% |
| Quarter to Dec 31, 2020 | Mar 30, 2021 | −3.0% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| SRX Global — Investor Presentation (July 2026) | Investor deck | 18 slides | July 2026 |
| SRX Global — Investor Presentation (June 2026) | Investor deck | 18 slides | Jun 26, 2026 |
| Merger or Acquisition (December 2025) | Merger or acquisition | 18 slides | Dec 16, 2025 |
| Investor Presentation (June 2025) | Investor deck | 19 slides | June 2025 |
| Investor Presentation (May 2025) | Investor deck | 17 slides | May 2025 |
| Better Choice — Investor Presentation (November 2024) | Investor deck | 17 slides | Nov 5, 2024 |
| Better Choice — Merger or Acquisition (September 2024) | Merger or acquisition | 20 slides | Sep 9, 2024 |
| Better Choice — Q3 2022 Earnings Presentation | Earnings | 16 slides | Nov 10, 2022 |
| Better Choice — Q2 2022 Earnings Presentation | Earnings | 20 slides | Aug 11, 2022 |
| Better Choice — Q1 2022 Earnings Presentation | Earnings | 17 slides | May 12, 2022 |
All 21 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Better Choice — Q4 2021 Earnings Presentation | Earnings | 15 slides | Mar 29, 2022 |
| Better Choice — 34th Annual Roth Conference (March 2022) | Conference | 12 slides | Mar 14, 2022 |
| Better Choice — D.A. Davidson 5th Annual Consumer Growth Conference (March 2022) | Conference | 15 slides | Mar 10, 2022 |
| Better Choice — Q3 2021 Earnings Presentation | Earnings | 20 slides | Nov 10, 2021 |
| Better Choice — Q2 2021 Earnings Presentation | Earnings | 27 slides | Aug 12, 2021 |
| Better Choice — Q1 2021 Earnings Presentation | Earnings | 23 slides | May 13, 2021 |
| Better Choice — FY2020 Earnings Presentation | Earnings | 24 slides | Mar 31, 2021 |
| Better Choice — 4th Annual D.A. Davidson Consumer Growth Conference (March 2021) | Conference | 19 slides | Mar 10, 2021 |
| Better Choice — Q3 2020 Earnings Presentation | Earnings | 16 slides | Nov 18, 2020 |
| Better Choice — Investor Presentation (August 2020) | Investor deck | 26 slides | Aug 4, 2020 |
| Better Choice — Investor Presentation (May 2020) | Investor deck | 22 slides | May 7, 2020 |
Financings
| Raise | Date |
|---|---|
| Convertible notes Closed: US$7.3M raised Insiders: Financing led by insiders and existing investors Use of proceeds: Support U.S. acquisition pipeline, Canadian specialty pharma footprint, next-generation capabilities and working capital | Jul 8, 2025 |
| Equity line of credit Announced: US$50M Use of proceeds: Pursue accretive U.S. M&A and scale specialty pharma platform in Canada | Jul 8, 2025 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2025 | FY2024 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.53M | 35.0M | 38.6M | 54.7M | 46.0M | 42.6M | 15.6M | 14.8M | 475 | |
| Cost of revenue | 5.01M | 22.0M | 26.8M | 39.4M | 30.6M | 26.5M | 9.72M | 7.49M | 211 | |
| Gross profit | 1.53M | 13.0M | 11.8M | 15.3M | 15.4M | 16.1M | 5.86M | 7.30M | 264 | |
| Research and development | 100.0K | 100.0K | 500.0K | 500.0K | 100.0K | |||||
| Selling, general and administrative | 12.9M | 19.0M | 24.4M | 35.4M | 28.5M | 34.5M | ||||
| Operating income | -11.4M | -5.97M | -21.2M | -38.8M | -17.3M | -27.3M | -36.3M | -5.16M | -527.9K | |
| Depreciation and amortization | 31.0K | 130.0K | 4.39M | 1.68M | 1.69M | 1.66M | 1.75M | 171.0K | 14.0K | |
| EBITDA | -11.4M | -5.84M | -19.5M | -37.1M | -15.6M | -25.6M | -36.2M | -5.14M | ||
| Interest expense | 628.0K | 467.0K | 1.35M | 551.0K | 9.20M | 700.0K | 868.0K | 532.9K | ||
| Income before tax | -8.64M | -159.0K | -22.8M | -39.3M | 3.42M | -59.3M | -1.11M | |||
| Income tax | 9.00K | 2.00K | -18.0K | 37.0K | 0 | 0 | 0 | |||
| Net income | -45.0M | -168.0K | -43.1M | -22.8M | -39.3M | 3.39M | -59.3M | -184.5M | -6.03M | -2.95M |
| Earnings per share, basic | -2.13 | -0.10 | -1.95 | -32.29 | -58.93 | 0.15 | -7.26 | -5.55 | -0.52 | -0.98 |
| Earnings per share, diluted | -2.13 | -0.10 | -1.95 | -32.29 | -58.93 | 0.14 | -7.26 | -5.55 | -0.52 | -0.98 |
Balance sheet
| Line | FY2025 | FY2025 | FY2024 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.31M | 3.07M | 106.0K | 4.46M | 3.17M | 21.7M | 3.93M | 2.36M | 3.95M | 199.7K |
| Receivables | 3.94M | 5.37M | 9.28M | 4.35M | 6.74M | 6.79M | 4.63M | 5.82M | 116.0K | |
| Inventory | 2.08M | 3.87M | 3.37M | 6.61M | 10.3M | 5.25M | 4.87M | 6.58M | 1.56M | 9.40K |
| Current assets | 8.13M | 15.0M | 13.6M | 16.2M | 27.5M | 43.9M | 17.6M | 17.6M | 5.89M | 209.1K |
| Property, plant and equipment | 88.0K | 138.0K | 6.03M | 230.0K | 375.0K | 369.0K | 252.0K | 417.0K | 71.0K | |
| Goodwill | 405.0K | 405.0K | 0 | 18.6M | 18.6M | 18.6M | 0 | |||
| Total assets | 8.40M | 15.8M | 33.8M | 16.7M | 38.7M | 74.7M | 51.3M | 53.5M | 5.99M | 209.1K |
| Accounts payable | 2.15M | 3.14M | 39.8M | 6.93M | 2.93M | 4.55M | 3.14M | 4.05M | 765.0K | 39.1K |
| Current liabilities | 3.54M | 7.15M | 81.3M | 13.7M | 5.58M | 7.34M | 54.6M | 33.0M | 9.03M | 2.86M |
| Long-term debt | 0 | 2.41M | 696.0K | 11.4M | 9.41M | 24.6M | 16.4M | 0 | 0 | |
| Total debt | 0 | 2.41M | 36.0M | 4.62M | 11.6M | 10.3M | 32.6M | 37.3M | 6.20M | 1.03M |
| Total liabilities | 8.00M | 7.15M | 88.9M | 13.8M | 17.1M | 16.8M | 79.4M | 50.0M | 9.03M | |
| Shareholders' equity | 407.0K | -63.7M | -55.1M | 2.95M | 21.5M | 57.9M | -28.1M | -7.07M | -3.04M | -2.65M |
| Shares outstanding | 416.5K | 1.83M | 22.5M | 729.0K | 668.9K | 29.1M | 8.65M | 48.0M | 11.7M | 3.06M |
Cash flow
| Line | FY2025 | FY2025 | FY2024 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -8.14M | -4.36M | -1.48M | 97.0K | -20.6M | -11.9M | -7.50M | -21.0M | -6.90M | -842.4K |
| Capital spending | -41.0K | -18.0K | -198.0K | -353.0K | -151.0K | -110.0K | -31.0K | |||
| Free cash flow | -4.40M | 79.0K | -20.8M | -12.2M | -7.66M | -21.1M | -6.93M | |||
| Cash from investing | 5.91M | -2.25M | -1.09M | -18.0K | -198.0K | -353.0K | -151.0K | -20.2M | -31.0K | 0 |
| Cash from financing | 12.2M | 5.22M | 932.0K | -5.10M | 1.28M | 37.2M | 9.11M | 39.8M | 10.7M | 1.00M |
| Share buybacks | 0 | -1.60M | 0 | 0 | ||||||
| Change in cash | 1.41M | -1.39M | -1.64M | -5.02M | -19.5M | 25.0M | 1.46M | -1.41M | 3.79M | 159.1K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| SCHEDULE 13D · Big-stake notice | Nov 20, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Oct 7, 2026 | Material contract | SEC |
| 8-K · Current report | Oct 6, 2026 | Current report | SEC |
| 8-K · Current report | Sep 9, 2026 | Material contract | SEC |
| 8-K · Current report | Sep 2, 2026 | Material contract | SEC |
| 8-K · Current report | Aug 28, 2026 | Material contract | SEC |
| 8-K · Current report | Aug 19, 2026 | Results | SEC |
| 10-Q · Quarterly report | Aug 13, 2026 | Quarterly report | SEC |
| 8-K/A · Current report, amended | Jul 29, 2026 | Financing | SEC |
| 8-K · Current report | Jul 28, 2026 | Financing | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Jul 21, 2026 | Material contract | SEC |
| 424B3 · Prospectus | Jul 16, 2026 | Offer document | SEC |
| 424B3 · Prospectus | Jul 16, 2026 | Offer document | SEC |
| 8-K · Current report | Jul 16, 2026 | Current report | SEC |
| 8-K · Current report | Jul 15, 2026 | Current report | SEC |
| 8-K · Current report | Jul 10, 2026 | Current report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jul 8, 2026 | Big-stake notice | SEC |
| S-8 · Registration statement for employee plans | Jul 6, 2026 | Offer document | SEC |
| 8-K · Current report | Jun 26, 2026 | Current report | SEC |
| SCHEDULE 13G · Big-stake notice | Jun 25, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Jun 24, 2026 | Meeting outcome | SEC |
| DEFR14C | Jun 24, 2026 | Other filings | SEC |
| 8-K · Current report | Jun 18, 2026 | Current report | SEC |
| 424B3 · Prospectus | Jun 5, 2026 | Offer document | SEC |
| 424B3 · Prospectus | Jun 5, 2026 | Offer document | SEC |
| 10-Q · Quarterly report | May 14, 2026 | Quarterly report | SEC |
| EFFECT · Notice that a registration is effective | May 8, 2026 | Other filings | SEC |
| 424B3 · Prospectus | May 7, 2026 | Offer document | SEC |
| CORRESP · Letter to the SEC | May 5, 2026 | Other filings | SEC |
| S-4/A · Registration statement, amended | May 5, 2026 | Offer document | SEC |
| 8-K · Current report | Apr 22, 2026 | Current report | SEC |
| UPLOAD · Letter from the SEC | Apr 21, 2026 | Other filings | SEC |
| 8-K · Current report | Apr 17, 2026 | Current report | SEC |
| S-4 · Registration statement | Apr 14, 2026 | Offer document | SEC |
| 4 · Change in ownership | Apr 3, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Apr 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2026 | Insider trade | SEC |
| 8-K · Current report | Mar 18, 2026 | Material contract | SEC |
| 424B3 · Prospectus | Mar 6, 2026 | Offer document | SEC |
| 424B3 · Prospectus | Mar 6, 2026 | Offer document | SEC |
| 8-K · Current report | Mar 3, 2026 | Material contract | SEC |
| 424B3 · Prospectus | Feb 27, 2026 | Offer document | SEC |
| 424B3 · Prospectus | Feb 27, 2026 | Offer document | SEC |
| 424B3 · Prospectus | Feb 26, 2026 | Offer document | SEC |
| 424B3 · Prospectus | Feb 26, 2026 | Offer document | SEC |
| 8-K · Current report | Feb 20, 2026 | Current report | SEC |
| 10-Q · Quarterly report | Feb 13, 2026 | Quarterly report | SEC |
| 424B3 · Prospectus | Feb 13, 2026 | Offer document | SEC |
| 424B3 · Prospectus | Feb 13, 2026 | Offer document | SEC |
| SCHEDULE 13G · Big-stake notice | Feb 12, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Feb 11, 2026 | Current report | SEC |
| 8-K · Current report | Jan 8, 2026 | Current report | SEC |
| 424B3 · Prospectus | Dec 31, 2025 | Offer document | SEC |
| 424B3 · Prospectus | Dec 30, 2025 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Dec 30, 2025 | Other filings | SEC |
| 424B3 · Prospectus | Dec 29, 2025 | Offer document | SEC |
| CORRESP · Letter to the SEC | Dec 23, 2025 | Other filings | SEC |
| 8-K · Current report | Dec 23, 2025 | Meeting outcome | SEC |
| S-1/A · Registration statement, amended | Dec 23, 2025 | Offer document | SEC |
| 424B3 · Prospectus | Dec 16, 2025 | Offer document | SEC |
| 8-K · Current report | Dec 16, 2025 | Material contract | SEC |
| EFFECT · Notice that a registration is effective | Dec 16, 2025 | Other filings | SEC |
| 424B3 · Prospectus | Dec 15, 2025 | Offer document | SEC |
| CORRESP · Letter to the SEC | Dec 10, 2025 | Other filings | SEC |
| S-1/A · Registration statement, amended | Dec 10, 2025 | Offer document | SEC |
| 10-K · Annual report | Dec 5, 2025 | Annual report | SEC |
| 144 · Notice of proposed sale | Dec 3, 2025 | Other filings | SEC |
| 8-K · Current report | Nov 20, 2025 | Current report | SEC |
| D | Nov 17, 2025 | Other filings | SEC |
| 8-K · Current report | Nov 10, 2025 | Management or board change | SEC |
| S-1 · Registration statement | Nov 7, 2025 | Offer document | SEC |
| S-1 · Registration statement | Nov 4, 2025 | Offer document | SEC |
| 8-K · Current report | Oct 31, 2025 | Material contract | SEC |
| DEF 14C | Oct 20, 2025 | Meeting notice | SEC |
| 8-K · Current report | Oct 17, 2025 | Current report | SEC |
| 8-K · Current report | Oct 9, 2025 | Meeting outcome | SEC |
| PRE 14C | Oct 9, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Oct 7, 2025 | Insider trade | SEC |
| 8-K · Current report | Oct 6, 2025 | Management or board change | SEC |
| 10-Q · Quarterly report | Sep 30, 2025 | Quarterly report | SEC |
| 8-K · Current report | Sep 19, 2025 | Current report | SEC |
| DEF 14C | Aug 18, 2025 | Meeting notice | SEC |
| NT 10-Q · Late filing notice | Aug 14, 2025 | Explanation request | SEC |
| 8-K · Current report | Aug 14, 2025 | Material contract | SEC |
| 8-K · Current report | Aug 12, 2025 | Current report | SEC |
| PRE 14C | Jul 29, 2025 | Meeting notice | SEC |
| 8-K · Current report | Jul 29, 2025 | Meeting outcome | SEC |
| 8-K · Current report | Jul 16, 2025 | Management or board change | SEC |
| 8-K · Current report | Jul 15, 2025 | Material contract | SEC |
| 8-K/A · Current report, amended | Jul 11, 2025 | Current report | SEC |
| 8-K · Current report | Jun 13, 2025 | Management or board change | SEC |
| SEC STAFF ACTION | Jun 3, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | May 15, 2025 | Quarterly report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 15, 2025 | Big-stake notice | SEC |
| 8-K · Current report | May 7, 2025 | Current report | SEC |
| 3 · Initial statement of ownership | May 7, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | May 7, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | May 7, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | May 7, 2025 | Insider trade | SEC |
| 8-K · Current report | Apr 30, 2025 | Acquisition or disposal | SEC |
| 8-K · Current report | Apr 29, 2025 | Current report | SEC |
| 8-K · Current report | Apr 25, 2025 | Current report | SEC |
| 8-K · Current report | Apr 17, 2025 | Material contract | SEC |
| 8-K · Current report | Apr 17, 2025 | Current report | SEC |
| 8-K · Current report | Mar 31, 2025 | Meeting outcome | SEC |
| 8-K · Current report | Mar 31, 2025 | Results | SEC |
| 10-K · Annual report | Mar 31, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Mar 7, 2025 | Meeting notice | SEC |
| 8-K · Current report | Feb 19, 2025 | Current report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 14, 2025 | Big-stake notice | SEC |
| DEF 14A · Proxy statement | Jan 28, 2025 | Meeting notice | SEC |
| 8-K · Current report | Jan 28, 2025 | Material contract | SEC |
| UPLOAD · Letter from the SEC | Jan 7, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jan 6, 2025 | Other filings | SEC |
| PREM14A | Jan 6, 2025 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jan 2, 2025 | Other filings | SEC |
| 4 · Change in ownership | Dec 26, 2024 | Insider trade | SEC |
| PRE 14A · Preliminary proxy statement | Dec 26, 2024 | Meeting notice | SEC |
| 8-K · Current report | Dec 20, 2024 | Meeting outcome | SEC |
| 8-K · Current report | Dec 10, 2024 | Material contract | SEC |
| 4 · Change in ownership | Nov 27, 2024 | Insider trade | SEC |
| 8-K · Current report | Nov 15, 2024 | Results | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 14, 2024 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 13, 2024 | Quarterly report | SEC |
| DEF 14A · Proxy statement | Nov 5, 2024 | Meeting notice | SEC |
| 8-K · Current report | Nov 4, 2024 | Current report | SEC |
| 8-K · Current report | Oct 18, 2024 | Current report | SEC |
| 8-K · Current report | Sep 9, 2024 | Material contract | SEC |
| 1-A | Aug 29, 2024 | Other filings | SEC |
| 8-K · Current report | Aug 26, 2024 | Results | SEC |
| 10-Q · Quarterly report | Aug 14, 2024 | Quarterly report | SEC |
| SC 13G · Big-stake notice | Aug 9, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Aug 6, 2024 | Current report | SEC |
| 8-K · Current report | Aug 1, 2024 | Material contract | SEC |
| 424B1 · Prospectus | Jul 31, 2024 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Jul 30, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jul 25, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jul 25, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jul 25, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jul 25, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jul 24, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jul 24, 2024 | Other filings | SEC |
| S-1/A · Registration statement, amended | Jul 23, 2024 | Offer document | SEC |
| 8-K · Current report | Jul 15, 2024 | Current report | SEC |
| 8-K · Current report | Jul 12, 2024 | Current report | SEC |
| UPLOAD · Letter from the SEC | Jul 10, 2024 | Other filings | SEC |
| S-1 · Registration statement | Jul 5, 2024 | Offer document | SEC |
| 8-K · Current report | Jun 21, 2024 | Material contract | SEC |
| 8-K · Current report | May 24, 2024 | Current report | SEC |
| 8-K · Current report | May 21, 2024 | Results | SEC |
| 10-Q · Quarterly report | May 17, 2024 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | May 16, 2024 | Explanation request | SEC |
| 8-K · Current report | May 10, 2024 | Current report | SEC |
| 8-K · Current report | Apr 29, 2024 | Current report | SEC |
| 8-K · Current report | Apr 17, 2024 | Results | SEC |
| 8-K · Current report | Apr 16, 2024 | Current report | SEC |
| 10-K · Annual report | Apr 12, 2024 | Annual report | SEC |
| 8-K · Current report | Apr 4, 2024 | Management or board change | SEC |
| NT 10-K · Late filing notice | Apr 2, 2024 | Explanation request | SEC |
| 8-K · Current report | Mar 25, 2024 | Current report | SEC |
| 8-K · Current report | Mar 14, 2024 | Meeting outcome | SEC |
| DEF 14C | Feb 27, 2024 | Meeting notice | SEC |
| PRE 14C | Feb 16, 2024 | Meeting notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 14, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Feb 12, 2024 | Current report | SEC |
| 4 · Change in ownership | Feb 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 5, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 5, 2024 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Jan 18, 2024 | Offer document | SEC |
| 8-K · Current report | Nov 15, 2023 | Meeting outcome | SEC |
| 8-K · Current report | Nov 13, 2023 | Results | SEC |
| 10-Q · Quarterly report | Nov 13, 2023 | Quarterly report | SEC |
| 8-K · Current report | Sep 27, 2023 | Current report | SEC |
| DEF 14A · Proxy statement | Sep 26, 2023 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Sep 8, 2023 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Sep 8, 2023 | Meeting notice | SEC |
| 4 · Change in ownership | Sep 7, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Sep 7, 2023 | Insider trade | SEC |
| 8-K · Current report | Aug 29, 2023 | Management or board change | SEC |
| 8-K · Current report | Aug 22, 2023 | Results | SEC |
| 10-Q · Quarterly report | Aug 18, 2023 | Quarterly report | SEC |
| NT 10-Q/A · Late filing notice, amended | Aug 14, 2023 | Explanation request | SEC |
| 8-K · Current report | Aug 7, 2023 | Management or board change | SEC |
| 8-K · Current report | Jun 27, 2023 | Material contract | SEC |
| RW · Request to withdraw a registration | May 25, 2023 | Other filings | SEC |
| 8-K · Current report | May 16, 2023 | Management or board change | SEC |
| 8-K · Current report | May 12, 2023 | Results | SEC |
| 10-Q · Quarterly report | May 12, 2023 | Quarterly report | SEC |
| S-3 · Registration statement | May 1, 2023 | Offer document | SEC |
| 10-K · Annual report | Mar 28, 2023 | Annual report | SEC |
| 8-K · Current report | Mar 28, 2023 | Current report | SEC |
| 8-K · Current report | Mar 20, 2023 | Management or board change | SEC |
| 8-K/A · Current report, amended | Mar 2, 2023 | Management or board change | SEC |
| 8-K · Current report | Mar 2, 2023 | Management or board change | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 14, 2023 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 14, 2023 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 13, 2023 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 13, 2023 | Big-stake notice | SEC |
This page holds 200 of 565 filings. Open Filings
Cap table
Built by 6ix from SRx Health Solutions, Inc.’s releases · as of Aug 13, 2026
- Common shares
- 20,265,391
- Fully diluted
- 20,265,391
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 20,265,391 | Aug 13, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Aug 13, 2026 | 20,265,391 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| David White Other companies: Onconetix, Inc. (Chief Executive Officer · Since at least Mar 18, 2026); Art's-Way Manufacturing Co., Inc. (Board Member · Since at least Dec 1, 2016); Realbotix Corp (Chief Executive Officer · Mar 31, 2026 – Nov 4, 2026 · Past) | Director · Apr 24, 2025 – Apr 24, 2025 · Past |
| Sammy Dorf Other companies: Onconetix, Inc. (Director · Since at least Mar 19, 2026); ZeroStack Corp. (Executive Chairman, Director · Dec 5, 2024 – Dec 15, 2024 · Past) | Director · Since at least Nov 5, 2026 |
| Lionel Conacher Other companies: Destination XL Group, Inc. (Chairman of the Board and Interim Chief Executive Officer · Since at least Jun 11, 2018) | Director · Sep 28, 2021 – Dec 26, 2024 · Past |
| Adesh Anil Vora | Executive Chairman, Director · Apr 24, 2025 – Apr 24, 2025 · Past |
| Arlene Dickinson | Director · Sep 28, 2021 – Feb 5, 2024 · Past |
| Davender Sohi | President · Apr 24, 2025 – Apr 24, 2025 · Past |
| Donald Young | Chief Sales Officer · Jun 29, 2021 – Jan 11, 2023 · Past |
| Eric Jackson | President, EMJX Platform and Head of Asset Management · Since at least Jun 18, 2026 |
| Gil Fronzaglia | Director · Jun 29, 2021 – Feb 5, 2024 · Past |
| John M Word III | Director · Jun 29, 2021 – Feb 5, 2024 · Past |
All 19 people
| Person | Seat |
|---|---|
| Joshua Epstein | Director · Since at least Oct 1, 2025 |
| Kent Cunningham | Chief Executive Officer · Since at least Jun 26, 2024 |
| Lori Taylor | Director · Jun 29, 2021 – Jul 8, 2021 · Past |
| Michael Young | Chairman of the Board · Since at least Jun 29, 2021 |
| Nina Martinez | Chief Financial Officer · Since at least Jun 18, 2026 |
| Robert Sauermann | COO · May 16, 2022 – Jan 11, 2023 · Past |
| Scott Lerner | Former CEO · Jun 29, 2021 – Oct 14, 2022 · Past |
| Sharla A Cook | CFO · Jun 29, 2021 – Jan 11, 2023 · Past |
| Simon Conway | Director · Since at least Apr 24, 2025 |
Log in to ask 6ix AI your own questions about SRx Health Solutions, Inc.